||
科学家已经开发出一种测量癌症药物达到体内目标的方法。它能实时显示肿瘤中的单个癌细胞,揭示哪些细胞与药物相互作用,哪些药物不能到达细胞。这些发现有助于临床医生决定癌症患者的最佳疗程和治疗方案。
https://www.sciencedaily.com/releases/2018/07/180712114456.htm
Hugh Sparks, Hiroshi Kondo, Steven Hooper, Ian Munro, Gordon Kennedy, Christopher Dunsby, Paul French, Erik Sahai. Heterogeneity in tumor chromatin-doxorubicin binding revealed by in vivo fluorescence lifetime imaging confocal endomicroscopy. Nature Communications, 2018; 9 (1) DOI: 10.1038/s41467-018-04820-6
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-9-27 06:37
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社